Appointment booking for Dr. Elfatih Abter, MD is currently not available.Dr. Elfatih Abter, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Elfatih Abter, MD (he/him) is a Infectious Disease Doctor in Lapeer, MI with over 17 years of experience. What is your opinion of Dr. Elfatih Abter, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Elfatih Abter, MD has received over $1,297 which includes payments from the following companies:
$498.42 from Gilead Sciences Inc
$160.98 from Insmed, Inc.
$117.04 from Merck Sharp & Dohme Corporation
$93.25 from Theravance Biopharma Inc.
$91.95 from AbbVie, Inc.
$74.92 from Allergan Inc.
$37.88 from Pfizer Inc.
$26.19 from Spiracur Inc.
$24.47 from Boston Scientific Corporation
$23.96 from Smith & Nephew, Inc.
$22.45 from The Medicines Company
$19.53 from Ethicon US, LLC
$19.36 from Actavis Pharma Inc
$18.85 from Cardiovascular Systems Inc.
$16.28 from Janssen Biotech, Inc.
$15.41 from Otsuka America Pharmaceutical, Inc.
$12.98 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11.79 from Oxford Immunotec Inc.
$11.60 from Integra LifeSciences Corporation
Payments received by Dr. Elfatih Abter, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!